Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("DURRINGTON, Paul")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 53

  • Page / 3
Export

Selection :

  • and

HDL in risk prediction and its direct and indirect involvement in atherogenesisDURRINGTON, Paul.Atherosclerosis. Supplement (Amsterdam). 2002, Vol 3, Num 4, pp 3-12, issn 1567-5688, 10 p.Article

Recent advances in high density lipoprotein and atherosclerosisDURRINGTON, Paul.Atherosclerosis. Supplement (Amsterdam). 2002, Vol 3, Num 4, issn 1567-5688, 70 p.Serial Issue

Paraoxonase and coronary heart diseaseMACKNESS, Michael I; MACKNESS, Bharti; DURRINGTON, Paul N et al.Atherosclerosis. Supplement (Amsterdam). 2002, Vol 3, Num 4, pp 49-55, issn 1567-5688, 7 p.Article

Hugh Sinclair Lecture: The regulation and remodelling of HDL by plasma factorsBARTER, P. J.Atherosclerosis. Supplement (Amsterdam). 2002, Vol 3, Num 4, pp 39-47, issn 1567-5688, 9 p.Article

Clinical management of children and young adults with heterozygous familial hypercholesterolaemia in the UKGREENE, Owen; DURRINGTON, Paul.Journal of the Royal Society of Medicine. 2004, Vol 97, Num 5, pp 226-229, issn 0141-0768, 4 p.Article

Squalene synthase inhibitors : Clinical pharmacology and cholesterol-lowering potentialCHARLTON-MENYS, Valentine; DURRINGTON, Paul N.Drugs (Basel). 2007, Vol 67, Num 1, pp 11-16, issn 0012-6667, 6 p.Article

ATP-binding cassette A1 protein and HDL homeostasisOWEN, James S; MULCAHY, Jane V.Atherosclerosis. Supplement (Amsterdam). 2002, Vol 3, Num 4, pp 13-22, issn 1567-5688, 10 p.Article

Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolaseTSELEPIS, Alexandros D; CHAPMAN, M. John.Atherosclerosis. Supplement (Amsterdam). 2002, Vol 3, Num 4, pp 57-68, issn 1567-5688, 12 p.Article

Hypercholesterolaemia and its managementBHATNAGAR, Deepak; SORAN, Handrean; DURRINGTON, Paul N et al.BMJ. British medical journal (International ed.). 2008, Vol 337, Num 7668, pp 503-508, issn 0959-8146, 6 p.Article

Use of the TLX ultracentrifuge for the isolation of different density lipoproteins and effects of freeze/thawing of human plasma before ultracentrifugationCHARLTON-MENYS, Valentine; CHOBOTOVA, Jelena; DURRINGTON, Paul N et al.Clinical chemistry and laboratory medicine. 2008, Vol 46, Num 9, pp 1285-1288, issn 1434-6621, 4 p.Article

Semiautomated method for determination of serum paraoxonase activity using paraoxon as substrateCHARLTON-MENYS, Valentine; YIFEN LIU; DURRINGTON, Paul N et al.Clinical chemistry (Baltimore, Md.). 2006, Vol 52, Num 3, pp 453-457, issn 0009-9147, 5 p.Article

HDL therapy for the acute treatment of atherosclerosisNEWTON, Roger S; KRAUSE, Brian R.Atherosclerosis. Supplement (Amsterdam). 2002, Vol 3, Num 4, pp 31-38, issn 1567-5688, 8 p.Article

Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDLANGELIN, Bo; PARINI, Paolo; ERIKSSON, Mats et al.Atherosclerosis. Supplement (Amsterdam). 2002, Vol 3, Num 4, pp 23-30, issn 1567-5688, 8 p.Article

The role of hydrostatic pressure in foam cell formation upon exposure of macrophages to LDL and oxidized LDLEVANS, Carol E; MYLCHREEST, Sarah; CHARLTON-MENYS, Valentine et al.Atherosclerosis. 2008, Vol 197, Num 2, pp 596-601, issn 0021-9150, 6 p.Article

Atorvastatin administration is associated with dose-related changes in IGF bioavailabilityNARAYANAN, Ram P; GITTINS, Matthew; SIDDALS, Kirk W et al.European journal of endocrinology. 2013, Vol 168, Num 4, pp 543-548, issn 0804-4643, 6 p.Article

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia : a prospective registry study. CommentaryREES, Alan; NEIL, Andrew; COOPER, Jackie et al.European heart journal. 2008, Vol 29, Num 21, issn 0195-668X, 2583-2584, 2625-2633 [11 p.]Article

ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)CATAPANO, Alberico L; REINER, Zeljko; ERDINE, Serap et al.Atherosclerosis. 2011, Vol 217, Num 1, pp 3-46, issn 0021-9150, 44 p.Article

Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheepMACKNESS, Bharti; DURRINGTON, Paul; POVEY, Andrew et al.Pharmacogenetics (London). 2003, Vol 13, Num 2, pp 81-88, issn 0960-314X, 8 p.Article

The UKPKDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). CommentarySTEVENS, Richard J; KOTHARI, Viti; ADLER, Amanda I et al.Clinical science (1979). 2001, Vol 101, Num 6, pp 671-682, issn 0143-5221, 11 p.Article

Association of LDL Cholesterol, Non―HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins: A Meta-analysisMATTHIJS BOEKHOLDT, S; ARSENAULT, Benoit J; DEMICCO, David A et al.JAMA, the journal of the American Medical Association. 2012, Vol 307, Num 12, pp 1302-1309, issn 0098-7484, 8 p.Article

Estimating the Health Benefits and Costs Associated with Ezetimibe Coadministered with Statin Therapy Compared with Higher Dose Statin Monotherapy in Patients with Established Cardiovascular Disease : Results of a Markov Model for UK Costs Using Data RegistriesARA, Roberta; PANDOR, Abdullah; TUMUR, Indra et al.Clinical therapeutics. 2008, Vol 30, Num 8, pp 1508-1523, issn 0149-2918, 16 p.Article

Joint British recommendations on prevention of coronary heart disease in clinical practiceWOOD, David; DURRINGTON, Paul; POULTER, Neil et al.Heart. Supplement. 1998, Vol 80, Num 2, 30 p.Serial Issue

The effect of atorvastatin on serum lipoproteins in acromegalyMISHRA, Manoj; DURRINGTON, Paul; MACKNESS, Mike et al.Clinical endocrinology (Oxford. Print). 2005, Vol 62, Num 6, pp 650-655, issn 0300-0664, 6 p.Article

Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemiaCASLAKE, Muriel J; STEWART, Grace; PACKARD, Chris J et al.Atherosclerosis. 2003, Vol 171, Num 2, pp 245-253, issn 0021-9150, 9 p.Article

Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dipCHERRY, Nicola; MACKNESS, Mike; DURRINGTON, Paul et al.Lancet (British edition). 2002, Vol 359, Num 9308, pp 763-764, issn 0140-6736Article

  • Page / 3